uBriGene to Showcase Innovations at ASH 2024

uBriGene is excited to announce our participation in the 66th ASH Annual Meeting and Exposition, the world's most comprehensive hematology event of the year, taking place from December 7-10, 2024, at the San Diego Convention Center, CA.

This prestigious event provides an invaluable educational experience, showcasing thousands of scientific abstracts that highlight the latest advancements and hot topics in hematology.

We invite you to visit our booth 1720, where we will feature a poster on our groundbreaking research topic: “RNA-LNP-Mediated CAR-T Cell Manufacturing: A Paradigm Shift in Precision Immunotherapy.”

As the landscape of cancer treatment evolves, chimeric antigen receptor T (CAR-T) cell therapies are revolutionizing how we approach the disease by harnessing the immune system's potential to target and eliminate cancer cells. However, the manufacturing of CAR-T cells presents significant challenges, including genetic modification risks and the need for scalable, efficient solutions.

Our study introduces a novel RNA-lipid nanoparticle (RNA-LNP) technology that enables the efficient and safe delivery of therapeutic RNAs—such as messenger RNA (mRNA), circular RNA (circRNA), and self-amplifying RNA (saRNA)—into T cells, thereby enhancing the CAR-T cell manufacturing process.

Join us at ASH 2024 to explore the future of hematology and learn more about our innovative approaches to CAR-T cell therapies. We look forward to connecting with fellow researchers and industry professionals!